Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Related Posts
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.
In early 2020, the Food and Drug Administration responded to decades of escalating concerns about a commonly prescribed drug for…
Biden Administration Warns 9 Governors About Medicaid Losses Among Children
The Biden administration on Monday warned the governors of nine states of unusually high Medicaid coverage losses among children, suggesting…
White House Delays a Decision on Banning Menthol Cigarettes
The Biden administration is delaying a decision on whether to ban menthol cigarettes amid intense lobbying from tobacco companies, convenience…